lipoxin a4 has been researched along with Liver Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ali-Shah, ST; Börgeson, E; Colas, RA; Dalli, J; Godson, C; Guiry, PJ; Johnson, AM; Lee, YS; Serhan, CN; Sharma, K; Syed, GH; Till, A | 1 |
| El-Awady, MS; El-Kashef, HA; El-Tanbouly, GS; Megahed, NA; Salem, HA | 1 |
| Arroyo, V; Clària, J; Gaya, J; González-Périz, A; López-Parra, M; Miquel, R; Planagumà, A; Rodés, J; Titos, E | 1 |
3 other study(ies) available for lipoxin a4 and Liver Diseases
| Article | Year |
|---|---|
Lipoxin A4 Attenuates Obesity-Induced Adipose Inflammation and Associated Liver and Kidney Disease.
Topics: Adipose Tissue; Animals; Anti-Inflammatory Agents, Non-Steroidal; Autophagy; Inflammation; Kidney; Kidney Diseases; Lipoxins; Liver; Liver Diseases; Mice, Inbred C57BL; Obesity | 2015 |
The lipoxin A
Topics: Alanine Transaminase; Animals; Arachidonate 5-Lipoxygenase; Aspartate Aminotransferases; Bilirubin; Cecum; gamma-Glutamyltransferase; Heptanoic Acids; Interleukin-10; Interleukin-6; Ligation; Lipoxins; Liver; Liver Diseases; Male; NF-kappa B; Protective Agents; Rats, Sprague-Dawley; RNA, Messenger; Toll-Like Receptor 4 | 2017 |
Inhibition of 5-lipoxygenase-activating protein abrogates experimental liver injury: role of Kupffer cells.
Topics: 5-Lipoxygenase-Activating Proteins; Animals; Arachidonate 5-Lipoxygenase; Carbon Tetrachloride; Carrier Proteins; Cell Count; Chemical and Drug Induced Liver Injury; Chronic Disease; Disease Models, Animal; Hepatocytes; Kupffer Cells; Leukotrienes; Lipoxins; Lipoxygenase Inhibitors; Liver; Liver Diseases; Male; Matrix Metalloproteinase 2; Membrane Proteins; Quinolines; Rats; Rats, Wistar; RNA, Messenger; Tissue Inhibitor of Metalloproteinase-2 | 2005 |